NDUFA2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
Also known as: B8, NDUA2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43678
- Gene
- NDUFA2
- Ensembl
- ENSG00000131495
- Chromosome
- 5
- Canonical length
- 99 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
The encoded protein is a subunit of the hydrophobic protein fraction of the NADH:ubiquinone oxidoreductase (complex 1), the first enzyme complex in the electron transport chain located in the inner mitochondrial membrane, and may be involved in regulating complex I activity or its assembly via assistance in redox processes. Mutations in this gene are associated with Leigh syndrome, an early-onset progressive neurodegenerative disorder. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
99 residues, UniProt reviewed canonical sequence.
>O43678|NDUFA2
1 MAAAAASRGV GAKLGLREIR IHLCQRSPGS QGVRDFIEKR YVELKKANPD LPILIRECSD
61 VQPKLWARYA FGQETNVPLN NFSADQVTRA LENVLSGKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NDUFA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 266 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 266 nTPM
- heart muscle: 239 nTPM
- choroid plexus: 234 nTPM
- tongue: 217 nTPM
- kidney: 204 nTPM
- liver: 182 nTPM
Single-cell type
- enterocytes: 614 nCPM
- parietal cells: 605 nCPM
- esophageal apical cells: 604 nCPM
- hepatocytes: 577 nCPM
- oocytes: 530 nCPM
- late spermatids: 488 nCPM
Immune cell
- total PBMC: 323 nTPM
- eosinophil: 313 nTPM
- classical monocyte: 306 nTPM
- plasmacytoid DC: 274 nTPM
- intermediate monocyte: 271 nTPM
- myeloid DC: 259 nTPM
Brain region
- white matter: 80 nTPM
- choroid plexus: 74 nTPM
- cerebellum: 73 nTPM
- hypothalamus: 69 nTPM
- spinal cord: 67 nTPM
- thalamus: 66 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NDUFA2.
Disease | AllUniProt
Conditions NDUFA2 is implicated in, by any mechanism.
- Mitochondrial complex I deficiency, nuclear type 13 (MC1DN13) MIM:618235
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 101 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial complex I deficiency, nuclear type 13
- Cystic Leukoencephalopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.77
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- -0.44
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- blastocyst hatching
- mitochondrial electron transport, NADH to ubiquinone
- proton motive force-driven mitochondrial ATP synthesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ribosomal protein/NADH dehydrogenase domain
- Thioredoxin-like superfamily
- Mitochondrial ribosomal protein L51 / S25 / CI-B8 domain
- NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NDUFA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NDUFA2 as an antibody target. Whether an autoantibody or antibody against NDUFA2 could matter depends on whether native NDUFA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NDUFA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NDUFA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...